Over the past five years, the cosmetic industry has met with several legislative changes. Within the new legislative package, including the new REACH and CLP, it is important to find a comfortable routine that will minimize costs while staying effective and compliant with all regulations.
Excelling in PV is not only about Technical Expertise
For a PV leader, to be successful can look like a daily Herculean work: meeting a crucial mandate to minimize harm to patients, while ensuring that a product is prescribed to the right population, and maintaining the highest level of compliance within a very complex set of worldwide regulations.
Acquiring and maintaining a solid technical expertise on the PV world is one fundamental step on this road to success. Understanding the subtleties of the regulations and knowing the trends which will design the future of PV is also key. However, in addition to the technical competencies and subject matter expertise, a set of new, non-traditional behavioral competencies must be acquired by PV teams to maximize their strategic and operational output. We can pick four worth considering.
Change Management: to adjust quickly and anticipate the next move, PV teams need to be savvy in organizational transformations and transactional performance. Operational excellence and high strategic output will only occur in organizations where there is a constant drive for challenging the status quo, find opportunities to increase operational efficiencies while maintaining an acute focus on compliance, quality and patient safety. This includes becoming a change agent, able to develop and implement a compelling vision, and recruit champions beyond the PV traditional perimeter.
Project Management: in a constantly changing environment where processes, systems and organizations evolve quickly, the execution of changes will be accelerated through the application of fundamental project management tools and methodology. Having a project management mindset will greatly facilitate the implementation of major transformations projects and will make a big difference in reaching the desired future state.
Build Partnerships and Alliances: as more operational activities and some key core competencies are transferred to external vendors, it is essential to know how to build an efficient and smooth collaborative mode with such partners. A relation of trust and confidence must be built, based on transparent and open communications. Expectations, performance metrics and clear accountability will minimize frustration. Using empathy in problem solving will help overcome the expected challenges and contribute to a successful team spirit. This is applicable to both internal and external partners.
Communication skills: Pharmacovigilance must take the lead on explaining its strategic contribution to the company vision and mission. The ability to draft and execute a multi-tier communication plan will help the recognition of PV as a unique and valuable expertise center. This communication campaign will also be a tremendous opportunity to learn more about others, recognize their own strategic contributions and capture potential synergies. This is another building element for superb team working.
Pharmacovigilance groups will be best equipped to fulfill the mission to protect patients if they recognize the need to foster such new behavioral competencies while maintaining a deep expertise on best PV practices and worldwide PV regulations.
Interested in this topic?
Advanced Protein Aggregation & Characterization
This training will focus on occurrence of particles in drug products, effects of protein aggregates, critical process and parameters. Attendees will gain overview of on utility and limits of predictive experiments, learn concerns from the authorities and relevant aggregation guidelines, and more.
CMC Analytical Comparability: Methods & Strategies for Biologics, Biosimilars & Biobetters
Attendees will be introduced to comparability in biosimilar development, the analytical strategies of protein characterization of biosimilars, the structure of proteins, in vitro pharmacology and much more.
Corporate Compliance & Transparency in the Pharmaceutical Industry
This two-day conference will serve as a platform for an open and dynamic dialogue with HCPs and patients to achieve common goals. Learn how to embed compliance in the business and develop one simple system for managing compliance & transparency in a complex and regulated environment.
Driving the national agenda of Medical tourism through PX Excellence
Read the interview with Dr. Layla Al-Marzouqi, Director of Medical Tourism Council at Dubai Health Authority, and learn how to enrich patient experience and quality of healthcare.
No more trouble with dangerous good shipments
Global temperature controlled pharmaceutical shipments are constantly faced with new logistics challenges and regulations. This January 2017, IATA Dangerous Goods Regulations added further complexity to shipping cold chain products compliantly.
5 Changes in Signal Detection Management
The European Medicines Agency, regulatory authorities in the Member States and marketing authorisation holders are responsible for detecting and managing safety signals. A safety signal is generally defined as information about a new or known Adverse Event that may have been caused by a medicine, where it is therefore necessary to conduct further investigation. Evaluation of safety signals plays a major role within pharmacovigilance. Therefore, it is vital for regulatory authorities to know the latest updates detailing the risks and benefits of medicines. The EudraVigilance database is an important source of information on suspected adverse reactions and signals.